2018 Annual Meeting of the American Association for the Study of Liver Diseases*

AASLD 2018 Program Image
November 9-13, 2018; San Francisco, California
Download slides or audio, review Capsule Summaries, and read ClinicalThought commentaries on practice-changing viral hepatitis and NAFLD/NASH data from San Francisco.

NAFLD/NASH

Capsule Summaries

Treatment with investigational agent generally well tolerated with most common treatment-emergent adverse event being mild gastrointestinal symptoms.

Released: November 15, 2018

Score based on noninvasive tests superior to Fib4 and NFS algorithms

Released: November 26, 2018

NIS4 diagnostic performance consistent between overall population of patients with NAFLD and subpopulations defined by sex or presence of obesity, type 2 diabetes, or metabolic syndrome.

Released: November 15, 2018

Diabetes was the most important driver of NAFLD risk in lean or obese individuals.

Released: November 16, 2018
Provided by Postgraduate Institute for Medicine
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Educational grant provided by:
AbbVie
Gilead Sciences

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?